CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,103,173 | -50.1% | 94,369 | -42.6% | 0.00% | -66.7% |
| Q2 2023 | $2,208,769 | -29.1% | 164,343 | -1.8% | 0.00% | -25.0% |
| Q4 2022 | $3,114,291 | +211.4% | 167,435 | +17.4% | 0.00% | +300.0% |
| Q2 2022 | $1,000,000 | -18.0% | 142,629 | -3.0% | 0.00% | 0.0% |
| Q1 2022 | $1,219,000 | +15.8% | 147,031 | -5.5% | 0.00% | 0.0% |
| Q4 2021 | $1,053,000 | +45.8% | 155,566 | +14.3% | 0.00% | 0.0% |
| Q3 2021 | $722,000 | -48.5% | 136,158 | -44.2% | 0.00% | -50.0% |
| Q2 2021 | $1,403,000 | +20.0% | 244,062 | -3.7% | 0.00% | +100.0% |
| Q1 2021 | $1,169,000 | +50.1% | 253,563 | +8.7% | 0.00% | 0.0% |
| Q4 2020 | $779,000 | +7.7% | 233,210 | -4.2% | 0.00% | 0.0% |
| Q3 2020 | $723,000 | – | 243,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,378,584 | $3,116,000 | 2.30% |
| TANAKA CAPITAL MANAGEMENT INC | 147,993 | $298,000 | 0.90% |
| SOPHROSYNE CAPITAL LLC | 282,500 | $638,000 | 0.56% |
| Ghost Tree Capital, LLC | 200,000 | $452,000 | 0.27% |
| Orbimed Advisors | 1,895,000 | $4,283,000 | 0.05% |
| Financial Architects, Inc | 30,000 | $68,000 | 0.04% |
| Cowen Prime Services LLC | 43,550 | $98,000 | 0.04% |
| Rotella Capital Management, Inc. | 12,300 | $28,000 | 0.03% |
| FEDERATED HERMES, INC. | 3,267,000 | $7,384,000 | 0.02% |
| Baker Brothers Advisors | 569,853 | $1,288,000 | 0.02% |